Scinovex
reviewTop 1% cited

Recent advances in the phencyclidine model of schizophrenia

American Journal of Psychiatry · 1991 · Vol. 148(10) · pp. 1301–1308
Daniel C. JavittStephen R. Zukin

Abstract

These findings suggest that endogenous dysfunction of NMDA receptor-mediated neurotransmission might contribute to the pathogenesis of schizophrenia. The relative implications of the PCP and amphetamine models of schizophrenia are discussed in relationship to the diagnosis and etiology of schizophrenia.

Schizophrenia research and treatmentNeurotransmitter Receptor Influence on BehaviorReceptor Mechanisms and SignalingPhencyclidinePsychotomimeticPsychosisNMDA receptorHallucinogenSchizophrenia (object-oriented programming)AmphetamineNeurosciencePharmacologyMescaline

MeSH terms

AnimalsDose-Response Relationship, DrugHumansMemoryPaired-Associate LearningPhencyclidinePhencyclidine AbuseSchizophreniaSchizophrenic PsychologyReceptors, N-Methyl-D-AspartateReceptors, PhencyclidineReceptors, NeurotransmitterMice
Citations
2,911
FWCI
20.35
field-weighted impact
References
91
Percentile
100%
vs. same field & year
Citations per year
References
Dementia Praecox or the Group of Schizophrenias
Journal of the American Medical Association · 1951 · 4,407 citations
Provocative tests with psychostimulant drugs in schizophrenia
Psychopharmacology · 1987 · 537 citations
Negative v Positive Schizophrenia
Archives of General Psychiatry · 1982 · 2,011 citations
The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia
Schizophrenia Bulletin · 1987 · 21,169 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Recent advances in the phencyclidine model of schizophrenia · Scinovex